Backing
Cantab Biopharmaceuticals Ltd is wholly owned by Celtic Pharma Holdings LP (CP2), a private equity firm. Financing for development of Cantab’s pipeline of products is provided by CP2. In-licensing of novel technologies and divestment of product assets are also achieved through CP2.